Evidence-Based Strategic Insights on Post-Discharge Transitions, Formula Selection & Brand Switching Behavior
Understand real-world enteral nutrition decisions and continuity across acute, post-acute, and home care
Study Type
Market Research
Positioning
Understand real-world enteral nutrition decisions and continuity across acute, post-acute, and home care
Sample Size
180 dietitians, physicians & nurses
Markets
U.S., Germany, and Japan
Respondent Type
Clinicians & decision-makers in enteral tube feeding management
Enteral tube feeding management extends well beyond inpatient hospital stays, with discharge and post-acute care shaping long-term product continuity and outcomes. However, the real-world insights into switching behavior and points of transitions in post-acute settings are limited.
This study assesses post-discharge care setting, formula and brand selection, switching behavior, and decision drivers across stroke, head and neck cancer, and gastrointestinal (GI) disorders, providing actionable intelligence for manufacturers and commercial teams operating across the full care continuum.
| Study Design | Cross-sectional survey; quantitative and structured. |
| Sample | 180 qualified clinicians responsible for enteral feeding decisions |
| Geographies | U.S., Germany, and Japan. |
| Focus Area | Stroke, Head & Neck Cancer, and gastrointestinal (GI) disorders |
| Analytical Approach | Quantitative and perception-based analysis capturing transition-of-care practices, brand patterns, and switching drivers. |
Discharge as inflection point
Post-discharge patient volumes substantially exceed inpatient volumes across all three conditions, reinforcing the importance of transition-of-care decisions for product continuity.
Home care channel dominance
Post-discharge management is primarily home based (67.6-85.9% across conditions), making home caregivers and home health services key levers for education and adherence.
Formula selection at discharge
Standard/complete formulas account for ~41% of discharge prescriptions; specialized, organic, and plant-based formulas each capture less than 15%, with slightly higher customization observed among GI patients.
Partial vs. exclusive feeding
Partial tube feeding is the dominant mode (~46-53% across conditions), supporting portfolio opportunities for supplementation and step-up/step-down regimens.
Competitive landscape
Nestlé Health Science leads post-discharge prescribing (~23% aggregate share); Abbott Nutrition and Nutricia/Danone form a strong secondary tier; together with Fresenius Kabi, the top four brands account for most discharge prescriptions. Kate Farms and Real Food Blends lead overall satisfaction scores despite holding limited discharge share.
Brand awareness benchmarked
Nestlé Health Science (4.30), Abbott Nutrition (4.44), Nutricia/Danone (4.17), and Fresenius Kabi (4.13) demonstrate the strongest recognition across the broadest respondent base. Otsuka and Morinaga/Clinico show very high awareness among Japanese respondents specifically. Mid-tier brands — B. Braun, Kate Farms, Real Food Blends — show moderate awareness with upside potential.
Brand continuity risk
Brand-specific prescribing is common (~74-81%), but inpatient-to-discharge brand changes occur frequently — stroke: 60%; head and neck cancer: 50%; GI: 40%.
Tolerability as primary driver
Tolerability toward a specific manufacturer portfolio is the most important factor influencing brand selection at discharge (importance score: 4.00, High tier) and the leading trigger for early switching at approximately one month — outweighing cost, peer influence, and formulary factors.
Satisfaction gaps by brand
Kate Farms and Real Food Blends lead overall satisfaction (5.67 and 5.62, respectively). Abbott Nutrition and Nestlé Health Science score highest on brand reputation and product options. Insurance coverage and manufacturer support are the weakest attributes across all brands, including Fresenius Kabi, Morinaga/Clinico, and Otsuka.
Stakeholder influence mapping
Physicians and dietitians hold the highest reported involvement in formula brand selection; facility managers contribute meaningfully in facility-based transitions; pharmacists report the lowest involvement across all brands and settings.
Fill the form to access full research
Massachusetts, USA
75 State Street, Ste 100,
Boston, Massachusetts, 02109, USA
Dusseldorf, Germany
Ground floor, Kaiserswerther Strasse 135
Dusseldorf, 40474, Germany
New Tehri, India
2G-34, Vidhi Vihar, New Tehri,
Tehri Gharwal, Uttarakhand - 249001, India
Ohio, USA
2435 E Gill Road,
Port Clinton OH 43452, USA
New South Wales, Australia
1 Denison St, North Sydney
New South Wales, 2060, Australia
Dehradun, India
1st floor, RR tower, Kargi Chowk,
Dehradun, Uttrakhand - 248001 India
© 2026 TehriHills Consulting. All rights reserved.